Doctor of Dentistry Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Brian Robinson

Dentist, Oral and Maxillofacial Surgery Rockville, MD Doctor of Dentistry

NPI 1194806984 CMS profile 280722

14955 Shady Grove Road, Suite 330, Rockville, MD 20850

Open in the dashboard

General payments

$3,815

48 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Brian Robinson of Rockville, MD is reported in the CMS Open Payments database as having received $3,815 across 48 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 85th percentile of Dentist, Oral and Maxillofacial Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,423 17
2024 General $834 15
2023 General $1,184 13
2022 General $261 2
2019 General $113 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Brian Robinson
  • Dentist, Oral and Maxillofacial Surgery median
  • Middle half of Dentist, Oral and Maxillofacial Surgery
  • National median

In program year 2025, general payments to Brian Robinson were reported at $1,423. Among 3,834 Dentist, Oral and Maxillofacial Surgery profiles paid that year, the median was $150 and the middle half received between $56 and $423.

Show as a table
Year Brian Robinson Dentist, Oral and Maxillofacial Surgery median Middle half National median
2019 $113 $142 $50–$420 $163
2020 $0 $96 $36–$277 $114
2021 $0 $138 $45–$419 $132
2022 $261 $144 $48–$367 $149
2023 $1,184 $153 $55–$399 $160
2024 $834 $152 $50–$400 $164
2025 $1,423 $150 $56–$423 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Zimvie Inc. $2,459 37 payments
  2. Merck Sharp & Dohme Corporation $1,035 7 payments
  3. Kerecis Limited $162 1 payment
  4. Zimmer Biomet Holdings, Inc. $113 1 payment
  5. BioHorizons Implant Systems Inc. $46 2 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $2,139 36 payments
  2. Travel and Lodging $1,476 9 payments
  3. Education $200 3 payments
Products named General payments · program years 2019–2025
  1. Tapered Screw-Vent $1,001 8 payments
  2. Tapered Screw-Vent Implant System $625 13 payments
  3. TSX Implants $385 8 payments
  4. Kerecis Omega3 SurgiClose Wound Care $162 1 payment
  5. Kerecis Omega3 GraftGuide $162 1 payment
  6. Kerecis Omega3 SurgiClose Wound Care $162 1 payment
  7. Kerecis Omega3 Marigen $162 1 payment
  8. Kerecis Omega3 SurgiClose Wound Care $162 1 payment
  9. 3i T3 $159 3 payments
  10. Bellatek $135 1 payment
  11. Other $394 10 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 9 drugs

Part D claims

323

Median for Oral Surgery (Dentist only): 288

Drug cost

$1,078

Median for Oral Surgery (Dentist only): $1,122

Branded share of claims

30.7%

Median for Oral Surgery (Dentist only): 18.4%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Etodolac Generic 50 $454
Penicillin V Potassium Generic 61 $154
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 83 $142
Clindamycin Hcl Generic 22 $87
Chlorhexidine Gluconate Generic 12 $64
Ibuprofen Generic 35 $60
Amoxicillin Generic 14 $50
Tramadol Hcl Generic 30 $34
Acetaminophen-Codeine Acetaminophen With Codeine Brand 16 $34

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 5,440 Part D prescribers listed as Oral Surgery (Dentist only); they describe a distribution and say nothing about conduct.

Records

48 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Dentist, Oral and Maxillofacial Surgery in Maryland

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record